The Working Group of IFFS, made an evaluatory analysis and recommendary study on "Cost Effective Approaches to IVF: Means to Improve Access" and submitted to FIGO which was published in 2006 in FIGO's Journal, International Jouranl of Gynecology & Obstetrics, in which following concluding recommendations were made, included in abstract and briefed in the paper as follows:
Abstract
Many childless couples would like to have access to in vitro fertilization
(IVF) through public-sector programs, but such programs are scant because of the
high costs that IVF entails today. A solution for health departments worldwide might
be to leave IVF methods requiring expensive equipment and ovarian stimulating
hormones — such as human recombinant gonadotropins, plus gonadotropin-releasing
hormone analogues to prevent a surge of luteinizing hormone — to the private sector.
Rather, health departments could focus on methods using less equipment and no
ovarian stimulating agent at all if possible. If not possible, inexpensive clomiphene
citrate could be used, combined with human menopausal gonadotropin if needed.
Before embryo transfer, oocyte maturation could occur in vitro or in a makeshift
incubator: a tube closed, wrapped, and left in the woman’s vagina for 24 h. To
prevent short- and long-term costs as well as possible lifelong problems, the transfer
of multiple embryos should not be performed.
D 2006 International Federation of Gynecology and Obstetrics. Published
Abstract
Many childless couples would like to have access to in vitro fertilization
(IVF) through public-sector programs, but such programs are scant because of the
high costs that IVF entails today. A solution for health departments worldwide might
be to leave IVF methods requiring expensive equipment and ovarian stimulating
hormones — such as human recombinant gonadotropins, plus gonadotropin-releasing
hormone analogues to prevent a surge of luteinizing hormone — to the private sector.
Rather, health departments could focus on methods using less equipment and no
ovarian stimulating agent at all if possible. If not possible, inexpensive clomiphene
citrate could be used, combined with human menopausal gonadotropin if needed.
Before embryo transfer, oocyte maturation could occur in vitro or in a makeshift
incubator: a tube closed, wrapped, and left in the woman’s vagina for 24 h. To
prevent short- and long-term costs as well as possible lifelong problems, the transfer
of multiple embryos should not be performed.
D 2006 International Federation of Gynecology and Obstetrics. Published
Abstract
Many childless couples would like to have access to in vitro fertilization
(IVF) through public-sector programs, but such programs are scant because of the
high costs that IVF entails today. A solution for health departments worldwide might
be to leave IVF methods requiring expensive equipment and ovarian stimulating
hormones — such as human recombinant gonadotropins, plus gonadotropin-releasing
hormone analogues to prevent a surge of luteinizing hormone — to the private sector.
Rather, health departments could focus on methods using less equipment and no
ovarian stimulating agent at all if possible. If not possible, inexpensive clomiphene
citrate could be used, combined with human menopausal gonadotropin if needed.
Before embryo transfer, oocyte maturation could occur in vitro or in a makeshift
incubator: a tube closed, wrapped, and left in the woman’s vagina for 24 h. To
prevent short- and long-term costs as well as possible lifelong problems, the transfer
of multiple embryos should not be performed.
D 2006 International Federation of Gynecology and Obstetrics. Published ABSTRACT: Many childless couples would like to have access to IVF through public sector programs, but such programs are scant because of the high cost that IVF entails today. A solution for health departments worldwide might be to leave IVF methods requiring expensive equipments and ovarian stimulating hormones - such as human recombinant gonadotropins, plus gonadotropin-releasing hormone analogues to prevent a surge of LH - to the private sector.
Rather, health departments could focus on methods using less equipments and no ovarian stimulating agent at all if possible. If not possible, inexpensive clomiphene citrate could be used combined with human menopausal gonadotropin if needed.
Before embryo transfer, oocyte maturation could occur invitro - or in a makeshift incubator: a tube closed, wrapped, and left in the woman's vagina for 24 hours.
Abstract
Many childless couples would like to have access to in vitro fertilization
(IVF) through public-sector programs, but such programs are scant because of the
high costs that IVF entails today. A solution for health departments worldwide might
be to leave IVF methods requiring expensive equipment and ovarian stimulating
hormones — such as human recombinant gonadotropins, plus gonadotropin-releasing
hormone analogues to prevent a surge of luteinizing hormone — to the private sector.
Rather, health departments could focus on methods using less equipment and no
ovarian stimulating agent at all if possible. If not possible, inexpensive clomiphene
citrate could be used, combined with human menopausal gonadotropin if needed.
Before embryo transfer, oocyte maturation could occur in vitro or in a makeshift
incubator: a tube closed, wrapped, and left in the woman’s vagina for 24 h. To
prevent short- and long-term costs as well as possible lifelong problems, the transfer
of multiple embryos should not be performed.
D 2006 International Federation of Gynecology and Obstetrics. Published
Abstract
Many childless couples would like to have access to in vitro fertilization
(IVF) through public-sector programs, but such programs are scant because of the
high costs that IVF entails today. A solution for health departments worldwide might
be to leave IVF methods requiring expensive equipment and ovarian stimulating
hormones — such as human recombinant gonadotropins, plus gonadotropin-releasing
hormone analogues to prevent a surge of luteinizing hormone — to the private sector.
Rather, health departments could focus on methods using less equipment and no
ovarian stimulating agent at all if possible. If not possible, inexpensive clomiphene
citrate could be used, combined with human menopausal gonadotropin if needed.
Before embryo transfer, oocyte maturation could occur in vitro or in a makeshift
incubator: a tube closed, wrapped, and left in the woman’s vagina for 24 h. To
prevent short- and long-term costs as well as possible lifelong problems, the transfer
The same document can be downloaded from FIGO's Website link given below:
http://www.figo.org/docs/World%20Report%20Pages%20287-291.pdf
http://www.figo.org/publications_world.asp (Cost Effective Approaches to In Vitro Fertilization: Means to Improve Access)
|